Year archive

CHIMERIC THERAPEUTICS LIMITED — 2025 filings

All 105 regulatory filings released by CHIMERIC THERAPEUTICS LIMITED (CHM) in 2025, sourced directly from the official regulator.

105 Filings

2025 Period

2025 filings (105)

Filing	Released	Lang
Application for quotation of securities - CHM 6 pages 18.5KB Share Issue/Capital Change	2025-12-30	English
Notice under section 708A 1 page 295.0KB Share Issue/Capital Change	2025-12-30	English
$8.4 M funding to drive CHM CDH17 and resignation of CMO 8 pages 297.8KB Capital/Financing Update	2025-12-22	English
Proposed issue of securities - CHM 5 pages 18.2KB Capital/Financing Update	2025-12-22	English
Proposed issue of securities - CHM 9 pages 31.9KB Capital/Financing Update	2025-12-22	English
Trading Halt 2 pages 216.3KB Capital/Financing Update	2025-12-18	English
Change of Director's Interest Notice - MP 2 pages 208.3KB Director's Dealing	2025-12-18	English
Notification regarding unquoted securities - CHM 6 pages 19.0KB Share Issue/Capital Change	2025-12-18	English
CDH17 granted FDA Orphan Drug Designation for Gastric Cancer 2 pages 207.5KB Regulatory Filings	2025-12-07	English
Company update-board changes, shareholder feedback & support 2 pages 195.6KB Board/Management Information	2025-11-27	English
Final Director's Interest Notice - PH 2 pages 684.2KB Director's Dealing	2025-11-25	English
Presentation to AGM 7 pages 2.4MB Investor Presentation	2025-11-24	English
Results of Meeting 2 pages 238.1KB Declaration of Voting Results & Voting Rights Announcements	2025-11-24	English
CHIMERIC RECEIVES $4.5M R&D TAX INCENTIVE 2 pages 708.6KB Regulatory Filings	2025-11-23	English
Pause in Trading 1 page 115.8KB Regulatory Filings	2025-11-12	English
CHM CORE NK Combination Phase 1b trial update 2 pages 219.8KB Regulatory Filings	2025-11-12	English
75% disease control observed in CHM CDH17 trial 2 pages 337.5KB Regulatory Filings	2025-11-12	English
Response to ASX Query Letter 11 pages 1.9MB Regulatory Filings	2025-11-05	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 1.0MB Interim / Quarterly Report	2025-10-30	English
Notice of Annual General Meeting/Proxy Form 32 pages 884.5KB AGM Information	2025-10-26	English
Application for quotation of securities - CHM 6 pages 18.7KB Share Issue/Capital Change	2025-10-09	English
Notification regarding unquoted securities - CHM 7 pages 22.6KB Share Issue/Capital Change	2025-10-09	English
Becoming a substantial holder 2 pages 68.1KB Major Shareholding Notification	2025-10-09	English
Presentation to investor webinar 24 pages 3.8MB Investor Presentation	2025-10-07	English
Investor update webinar - 11am AEDT, Wednesday 8 Oct 2 pages 569.9KB Regulatory Filings	2025-10-02	English
Additional complete responses in CHM CORE-NK Phase 1b trial 3 pages 668.2KB Regulatory Filings	2025-10-01	English
Disease control and tumour shrinkage observed in CHM CDH17 3 pages 340.1KB Regulatory Filings	2025-09-28	English
Presentation to investor webinar 18 pages 3.6MB Investor Presentation	2025-09-08	English
Appendix 4E and Annual Report 89 pages 3.6MB Annual Report	2025-08-28	English
Corporate Governance Statement and Appendix 4G 19 pages 896.7KB Governance Information	2025-08-28	English
Webinar - CHM CDH17 deep dive with Professor Jennifer Eads 2 pages 189.6KB Investor Presentation	2025-08-25	English
Change of Director's Interest Notice MP 2 pages 222.7KB Director's Dealing	2025-08-20	English
Application for quotation of securities - CHM 6 pages 18.7KB Share Issue/Capital Change	2025-08-06	English
Notification regarding unquoted securities - CHM 5 pages 17.2KB Share Issue/Capital Change	2025-08-06	English
CHM CDH17 Clinical Trial Update 3 pages 314.0KB Regulatory Filings	2025-08-03	English
Quarterly Activities/Appendix 4C Cash Flow Report 14 pages 1.3MB Interim / Quarterly Report	2025-07-28	English
Change in substantial holding - PH 3 pages 127.4KB Major Shareholding Notification	2025-07-28	English
Proposed issue of securities - CHM 5 pages 17.2KB Capital/Financing Update	2025-07-27	English
Application for quotation of securities - CHM 6 pages 18.6KB Share Issue/Capital Change	2025-07-24	English
Notification regarding unquoted securities - CHM 6 pages 21.1KB Share Issue/Capital Change	2025-07-24	English
Application for quotation of securities - CHM 6 pages 18.6KB Share Issue/Capital Change	2025-07-24	English
Notification regarding unquoted securities - CHM 6 pages 21.0KB Share Issue/Capital Change	2025-07-24	English
Update - Proposed issue of securities - CHM 8 pages 29.7KB Capital/Financing Update	2025-07-23	English
Presentation to Extraordinary General Meeting 11 pages 2.3MB Investor Presentation	2025-07-22	English
Results of Meeting 2 pages 166.9KB Declaration of Voting Results & Voting Rights Announcements	2025-07-22	English
Prospectus 47 pages 582.0KB Capital/Financing Update	2025-07-22	English
Proposed issue of securities - CHM 7 pages 26.7KB Capital/Financing Update	2025-07-22	English
Initial Director's Interest Notice 2 pages 258.6KB Director's Dealing	2025-07-01	English
Professor Miles Prince appointed as Non-Executive Director 3 pages 189.0KB Board/Management Information	2025-06-30	English
Change of Director's Interest Notice LR 2 pages 108.5KB Director's Dealing	2025-06-30	English
Notification of cessation of securities - CHM 4 pages 15.4KB Share Issue/Capital Change	2025-06-25	English
Notice of Extraordinary General Meeting/Proxy Form 33 pages 1.1MB AGM Information	2025-06-23	English
Translational data shows persistence of CHM CDH17 3 pages 291.0KB Regulatory Filings	2025-06-16	English
Chimeric receives $2.5 M advance on FY25 R&D tax incentive 2 pages 191.6KB Capital/Financing Update	2025-06-09	English
CHM CDH17 receives FDA Fast Track 3 pages 204.6KB Regulatory Filings	2025-06-03	English
Application for quotation of securities - CHM 6 pages 18.2KB Share Issue/Capital Change	2025-05-28	English
Change in substantial holding - PH 3 pages 127.9KB Major Shareholding Notification	2025-05-27	English
Prospectus 50 pages 457.1KB Capital/Financing Update	2025-05-25	English
Letter to Shareholders 5 pages 214.9KB Investor Presentation	2025-05-25	English
Application for quotation of securities - CHM 6 pages 18.3KB Capital/Financing Update	2025-05-25	English
Presentation to investor webinar 14 pages 2.0MB Investor Presentation	2025-05-21	English
CHM CDH17 ADVANCES TO DOSE LEVEL 2 8 pages 330.3KB Capital/Financing Update	2025-05-20	English
$6.6 million Placement to advance clinical trial pipeline 7 pages 249.1KB Capital/Financing Update	2025-05-19	English
Proposed issue of securities - CHM 5 pages 17.8KB Capital/Financing Update	2025-05-19	English
Proposed issue of securities - CHM 8 pages 29.7KB Capital/Financing Update	2025-05-19	English
Investor webinar 2 pages 176.3KB Capital/Financing Update	2025-05-19	English
Trading Halt 2 pages 276.3KB Capital/Financing Update	2025-05-15	English
Pause in Trading 1 page 115.1KB Regulatory Filings	2025-05-14	English
Trading Halt 2 pages 191.0KB Regulatory Filings	2025-05-14	English
ADVENT-AML Phase 1B clinical trial update 9 pages 244.1KB Regulatory Filings	2025-05-14	English
Application for quotation of securities - CHM 6 pages 18.6KB Share Issue/Capital Change	2025-05-08	English
Change of Director's Interest Notice 3 pages 117.3KB Director's Dealing	2025-04-30	English
Change of Director's Interest Notice PH 3 pages 117.5KB Director's Dealing	2025-04-30	English
Change in substantial holding 3 pages 124.4KB Major Shareholding Notification	2025-04-30	English
Application for quotation of securities - CHM 6 pages 18.6KB Share Issue/Capital Change	2025-04-29	English
Application for quotation of securities - CHM 6 pages 18.7KB Share Issue/Capital Change	2025-04-29	English
Completion of Entitlement Offer 3 pages 264.4KB Capital/Financing Update	2025-04-23	English
EMORY JOINS CHM CDH17 PHASE 1/2 CLINICAL TRIAL 3 pages 296.3KB Regulatory Filings	2025-04-23	English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 1.5MB Interim / Quarterly Report	2025-04-22	English
Letter to CHMAAC option holders 1 page 188.9KB Capital/Financing Update	2025-04-03	English
Entitlement Offer closing date extended to 22 April 2025 3 pages 314.5KB Capital/Financing Update	2025-04-02	English
Update - Proposed issue of securities - CHM 7 pages 24.2KB Capital/Financing Update	2025-04-02	English
Application for quotation of securities - CHM 6 pages 20.0KB Share Issue/Capital Change	2025-04-01	English
Option Exp 19 Dec 2025 Range of Units and Top 20 Holders 3 pages 303.2KB Major Shareholding Notification	2025-04-01	English
Entitlement Offer Documents 58 pages 1.3MB Capital/Financing Update	2025-03-24	English
US patent allowed for CHM CDH17 technology 2 pages 226.1KB Regulatory Filings	2025-03-24	English
Entitlement Offer to raise approximately $3.2 million 5 pages 342.8KB Capital/Financing Update	2025-03-17	English
Prospectus 51 pages 955.8KB Capital/Financing Update	2025-03-17	English
Update - Proposed issue of securities - CHM 7 pages 24.6KB Capital/Financing Update	2025-03-17	English
Proposed issue of securities - CHM 5 pages 17.1KB Capital/Financing Update	2025-03-17	English
Application for quotation of securities - CHM 6 pages 18.6KB Share Issue/Capital Change	2025-03-16	English
Presentation at NWR Virtual Healthcare Conference 2 pages 226.9KB Investor Presentation	2025-03-12	English
Chimeric announces intention to undertake Entitlement Offer 3 pages 262.3KB Capital/Financing Update	2025-03-03	English
Proposed issue of securities - CHM 7 pages 24.7KB Capital/Financing Update	2025-03-03	English
Reinstatement to Quotation 1 page 91.5KB Capital/Financing Update	2025-03-03	English
Suspension from Quotation 2 pages 677.9KB Regulatory Filings	2025-03-02	English
Half Year Report and Appendix 4D 31 December 2024 37 pages 1.5MB Interim / Quarterly Report	2025-02-27	English
Pause in Trading 1 page 117.2KB Regulatory Filings	2025-02-26	English
Trading Halt 2 pages 590.8KB Capital/Financing Update	2025-02-26	English
$4.0m Non-Dilutionary Funding 3 pages 253.8KB Capital/Financing Update	2025-02-26	English
Prospectus 40 pages 817.7KB Capital/Financing Update	2025-02-11	English
Application for quotation of securities - CHM 6 pages 18.3KB Share Issue/Capital Change	2025-02-11	English
Proposed issue of securities - CHM 4 pages 15.8KB Capital/Financing Update	2025-02-10	English
UChicago Medicine joins CHM CDH17 trial 2 pages 254.1KB Regulatory Filings	2025-02-09	English
Quarterly Activities/Appendix 4C Cash Flow Report 12 pages 854.0KB Interim / Quarterly Report	2025-01-30	English